ClinicalTrials.Veeva

Menu

Diclofenac vs Dexamethasone in Combined Surgery

S

Sheba Medical Center

Status

Completed

Conditions

Cataract
Glaucoma

Treatments

Drug: diclofenac drops
Drug: dexamethasone sodium phosphate 0.1% eye drops

Study type

Interventional

Funder types

Other

Identifiers

NCT00825864
SHEBA-03-3123-HLV-CTIL

Details and patient eligibility

About

To study the effect of Diclofenac drops or Dexamethasone drops on combined surgery of trabeculectomy and cataract surgery.

Enrollment

50 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients scheduled for combines surgery of trabeculectomy and cataract surgery

Exclusion criteria

  • severe complicated surgery like vitreal loss, expulsive hemorrhage, endophthalmitis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

50 participants in 2 patient groups

1diclofenac drops treatment
Active Comparator group
Description:
four times a day for 3 months
Treatment:
Drug: diclofenac drops
2dexamethasone drops
Active Comparator group
Treatment:
Drug: dexamethasone sodium phosphate 0.1% eye drops

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems